[1]
D. Moradpour, B. Müllhaupt, and Swiss Association for the Study of the Liver, “Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir”, Swiss Med Wkly, vol. 142, no. 0708, p. w13516, Feb. 2012.